Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-11-04 Huang Jane CMO, Hematology Sale −12,523 $190.00 $2.4M 15,808
2019-11-04 Huang Jane CMO, Hematology Sale −12,654 $191.01 $2.4M 3,154
2019-11-04 Huang Jane CMO, Hematology Sale −2,854 $191.96 $548K 300
2019-11-04 Huang Jane CMO, Hematology Sale −300 $192.77 $58K 0
2019-11-04 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) +427,700 617,075
2019-11-04 Chen Timothy Yung-Cheng Director Option exercise +4,000 $41.01 $164K 4,000
2019-11-04 Chen Timothy Yung-Cheng Director Sale −1,200 $189.37 $227K 2,800
2019-11-04 Chen Timothy Yung-Cheng Director Sale −1,394 $190.34 $265K 1,406
2019-11-04 Chen Timothy Yung-Cheng Director Sale −1,306 $191.32 $250K 100
2019-11-04 Chen Timothy Yung-Cheng Director Sale −100 $192.18 $19K 0
2019-11-04 Chen Timothy Yung-Cheng Director Sale −200 $192.06 $38K 0
2019-11-04 Chen Timothy Yung-Cheng Director Option exercise · Share Option (Right to Buy) +52,000 117,988

Page 99 of 99 · 1,972 trades